SummitTX Capital’s Qiagen QGEN Stock Holding History

SummitTX Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,233	Closed	-$234K	–	921
2025 Q3	$234K	Buy	+5,233	New	+$250K	0.01%	681

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SummitTX Capital's QGEN Position: Q4 2025 in Review

SummitTX Capital sold out of Qiagen (QGEN) in Q4 2025, closing a stake of 5,233 shares — an estimated $234K sold.

SummitTX Capital first reported a position in QGEN in Q3 2025 and held it in 1 quarter. The position peaked at $234K in Q3 2025. 321 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.

SummitTX Capital reported no remaining Qiagen position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 5,233 Qiagen shares in Q4 2025, an estimated $234K.
SummitTX Capital first reported a position in Qiagen in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Qiagen position peaked at $234K in Q3 2025.
321 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.